REGENERON PHARMACEUTICALS, INC. (REGN) Gross margin 2016–2020
REGENERON PHARMACEUTICALS, INC. (REGN) gross margin by fiscal year — reported gross profit divided by reported revenue.
95.3%FY2020 · since FY2016: 95.0% → 95.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | 95.3% | -1.1 pp |
| FY2019 | 96.4% | +0.3 pp |
| FY2018 | 96.1% | -0.6 pp |
| FY2017 | 96.7% | +1.7 pp |
| FY2016 | 95.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice